A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years

• Main Authors: Tino F. Schwarz (Author), Li-Min Huang (Author), Alejandra Valencia (Author), Falko Panzer (Author), Cheng-Hsun Chiu (Author), Annabelle Decreux (Author), Sylviane Poncelet (Author), Naveen Karkada (Author), Nicolas Folschweiller (Author), Lan Lin (Author), Gary Dubin (Author), Frank Struyf (Author)
• Format: Book
• Published: Taylor & Francis Group, 2019-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

This study assessed long-term immunogenicity and safety following 3 doses of AS04-adjuvanted human papillomavirus (HPV)-16/18 L1 virus-like particle (VLP) vaccine in females 10-14 years old. Girls included in the immunogenicity subset in the primary controlled, observer-blinded, randomized study (NC...